Alerts will be sent to your verified email
Verify Email
ISTRNETWK
|
iStreet Network
|
Bafna Pharma
|
Valiant Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.48 % | 0.0 | 9.66 % |
|
5yr average Equity Multiplier
|
-1.13 | 3.77 | 1.76 |
|
5yr Average Asset Turnover Ratio
|
0.21 | 0.42 | 0.81 |
|
5yr Avg Net Profit Margin
|
1.44 % | -36.55 % | 2.4 % |
|
Price to Book
|
170.75 | 5.07 | 0.9 |
|
P/E
|
56.83 | 26.83 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
22.21 Days | 0.18 Days | 75.62 Days |
|
Inventory Days
|
0.0 | 87.65 Days | 18.84 Days |
|
Days Receivable
|
220.87 Days | 132.64 Days | 161.25 Days |
|
Days Payable
|
39.73 Days | 210.48 Days | 82.33 Days |
|
5yr Average Interest Coverage Ratio
|
-107.0 | -5.68 | 44.93 |
|
5yr Avg ROCE
|
-79.54 % | -11.61 % | 7.68 % |
|
5yr Avg Operating Profit Margin
|
1.54 % | -21.98 % | 0.79 % |
|
5 yr average Debt to Equity
|
-1.09 | 1.41 | 0.48 |
|
5yr CAGR Net Profit
|
n/a | 12.0 % | n/a |
|
5yr Average Return on Assets
|
-113.8 % | -16.11 % | 4.39 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
46.24 % | 75.0 % | 74.94 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.04 % | -15.02 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
iStreet Network
|
Bafna Pharma
|
Valiant Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|